NCT00024245View on ClinicalTrials.gov

10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Study Completion Date

April 30, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pralatrexate

DRUG

probenecid

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00024245 - 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter